Form 4: Iradimed CFO John Glenn Receives Stock Awards

Iradimed's Chief Financial Officer, John Glenn, was granted restricted stock units and performance-based restricted stock units on December 11, 2024.

Summary

• John Glenn, the Chief Financial Officer of Iradimed Corporation, received stock awards on December 11, 2024.
• He was granted 5,436 restricted stock units (RSUs) and 5,435 performance-based restricted stock units (PRSUs).
• The RSUs vest in three equal annual installments starting December 11, 2025.
• The PRSUs vest over a three-year performance period from December 12, 2024, through December 11, 2027, based on the company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index.
• Both RSUs and PRSUs convert into common stock on a one-for-one basis.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of executive compensation through stock awards, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

• The stock awards align the CFO's interests with the long-term performance of the company.
• The vesting schedule of the RSUs encourages continued service by the CFO.
• The performance-based vesting of the PRSUs incentivizes the CFO to drive shareholder value.

Risks

• The value of the stock awards is subject to market fluctuations.
• The performance-based vesting of the PRSUs is dependent on the company's performance relative to the NASDAQ US Small Cap Medical Equipment index, which is outside of the company's direct control.

Future Outlook

The vesting of the stock awards is contingent on continued service and performance, aligning the CFO's interests with the company's long-term success.

Industry Context

Stock-based compensation is a common practice for incentivizing executives in the medical equipment industry, aligning their interests with shareholder value creation.

Comparison to Industry Standards

• Stock-based compensation is a standard practice in the medical device industry, with companies like Stryker, Medtronic, and Boston Scientific using similar methods to incentivize their executives.
• The vesting schedules and performance metrics are typical for executive compensation packages in this sector, often tied to company performance and market benchmarks.

Stakeholder Impact

• The stock awards may positively impact shareholder value if the CFO's performance leads to increased company success.
• The awards incentivize the CFO to work towards the long-term growth and profitability of the company.

Key Dates

Keywords

stock awards, restricted stock units, performance-based restricted stock units, equity incentive plan, insider trading, Iradimed, John Glenn, CFO